Raphael Pharmaceutical Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Mr. Ajay Kumar Dhadha voluntarily resigned from his positions as Chairman of the Board of Directors and Director of the Company, effective June 30, 2026.
Mr. Guy Ofir voluntarily resigned from his positions as Chief Financial Officer, General Counsel, and Director of the Company, effective July 16, 2026.
Effective July 16, 2026, the Company appointed Mr. Uri Tadelis as its Chief Financial Officer.
Extracted from this filing and checked against the source text.
Ajay Kumar Dhadha resigned as Chairman of the Board of Directors at Raphael Pharmaceutical Inc..
Mr. Ajay Kumar Dhadha voluntarily resigned from his positions as Chairman of the Board of Directors and Director of the Company, effective June 30, 2026.View on SEC.gov
Guy Ofir resigned as Chief Financial Officer, General Counsel, and Director at Raphael Pharmaceutical Inc..
Mr. Guy Ofir voluntarily resigned from his positions as Chief Financial Officer, General Counsel, and Director of the Company, effective July 16, 2026.View on SEC.gov
Uri Tadelis was appointed as Chief Financial Officer at Raphael Pharmaceutical Inc..
Effective July 16, 2026, the Company appointed Mr. Uri Tadelis as its Chief Financial Officer.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.